Medistim

Regulatory Filings • Oct 22, 2015

Medistim ASA enters into a strategic partnership with em-tec GmbH

Medistim ASA enters into a strategic partnership with em-tec GmbH

(Oslo, October 22nd 2015), Medistim ASA (OSE: MEDI), a

medtech company that develops and distributes surgical

guidance and quality assessment devices, has entered

into a long-term agreement with em-tec GmbH.

Under the License and OEM agreement, Medistim obtains

exclusive, eternal, world-wide rights to market and

sell em-tec's transit time flow measurement (TTFM)

technology for use on human blood vessels within

cardiac-, vascular- and transplant surgery. em-tec's

flow measurement device is designed as a basic, entry-

level customer solution that meets lower price-point

market segments and fills a gap within Medistim's

product portfolio. The first Medistim labeled device

will be launched in 2016.

The financial terms of the agreement consist of an

upfront payment of approx. EUR 300,000 and minimum

purchase commitments.

In addition to the License and OEM agreement, the

companies intend to collaborate on new technology and

product development, thereby strategically combining

the strengths of both companies.

"While Medistim is the market leader with our own high-

end products for surgical guidance and blood flow

measurement in cardiac-, vascular and transplant

surgery, we have been lacking an entry-level device to

reach some emerging market product segments," says

Medistim President and CEO, Kari E. Krogstad. "This

agreement gives us a time- and cost effective path to

serve these segments, while at the same time, it opens

up for very exciting opportunities from the two

companies joining forces to further technological

progress and engage in new product and technology

development".

About Medistim

Medistim is a medtech company that develops and

distributes ultrasound based surgical guidance and

quality assessment devices. With headquarters in

Oslo, Norway, Medistim was established in 1984, and

has a track record of profitable growth over the past

>10 years. The company is a pioneer within its

segment, and continues to invest in new product

development. Medistim has wholly owned subsidiaries

with sales organizations in the USA, Germany, UK,

Denmark and Norway, in addition to about 50

distributors in Europe, Asia, Middle East, Africa and

South America.

For more information, visit the Medistim home page:

www.medistim.com

About em-tec

em-tec GmbH was founded in 1988 near Munich. The

company has developed and produced successful products

approved for medical technology as well as non-medical

use, with a strong core competence in the field of non-

invasive transit time based flow measurement. em-tec

offers TTFM based products and components for e.g.

cardiovascular surgery, for use in laboratories or

bioprocesses. em-tec combines technological and

medical expertise, develops coherent solutions and

guarantees their customers innovative and economical

products. From the first idea to the market - em-

tec's vision is to be the ideal partner for all steps

of product development and contract manufacturing.

For more information, visit the em-tec home page:

www.em-tec.com

For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA

Tel: + 47 918 38 110

E-mail: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA

Tel: + 47 906 59 940

E-mail: thomas.jakobsen@medistim.com

This information is disclosed under Norwegian law

(Verdipapirhandelloven §5-12).